Heather Eng

Heather Eng

Pfizer Inc. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4396506
-
person_outline Heather Eng's MOST POPULAR ARTICLES
1-) An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19DR Owen, CMN Allerton, AS Anderson, L Aschenbrenner, M Avery, ...Science 374 (6575), 1586-1593, 202115582021
2-) Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19B Boras, RM Jones, BJ Anson, D Arenson, L Aschenbrenner, ...Nature communications 12 (1), 6055, 20212292021
3-) Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearanceAC Rand, SSF Leung, H Eng, CJ Rotter, R Sharma, AS Kalgutkar, ...MedChemComm 3 (10), 1282-1289, 20121402012
4-) Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of …KO Cameron, DW Kung, AS Kalgutkar, RG Kurumbail, R Miller, CT Salatto, ...Journal of Medicinal Chemistry 59 (17), 8068-8081, 20161222016
5-) Discovery of a novel inhibitor of coronavirus 3CL protease for the potential treatment of COVID-19B Boras, RM Jones, BJ Anson, D Arenson, L Aschenbrenner, ...BioRxiv, 2020.09. 12.293498, 20201202020